This page lists all known medications that could potentially lead to 'Monomorphic ventricular tachycardia' as a side effect. It's important to note that mild side effects are quite common with ...

Sustained monomorphic VT in nonischemic dilated cardiomyopathy (NDCMP) is less common than in ischemic cardiomyopathy. The pathophysiological basis for sustained monomorphic VT associated with NDCMP ...

We report the case of a 56-year-old man who had sudden palpitations, lightheadedness, chest pain, and dyspnea. Paramedics arrived within about 10 minutes after the onset of symptoms and found that the ...

In this Journal feature, information about a real patient is presented in stages (boldface type) to an expert clinician, who responds to the information, sharing his or her reasoning with the reader ...

The study examines the safety and effectiveness of Ultralow Temperature Cryoablation for treating sustained monomorphic ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy ...

A single noninvasive radiation therapy treatment safely reduced the burden of ventricular tachycardia, with effects persisting for 2 years in most patients, according to data from the ENCORE-VT trial ...

Ventricular tachycardia is a life threatening heart condition in which arrhythmic heart beats occur in the ventricles. The two lower chambers of the heart are known as ventricles. They are responsible ...

Adagio Medical Closes Financing of $19 Million Upfront; Positions Company to Advance Purpose-Built Technology for Treatment of Ventricular Tachycardia Proceeds Expected to Fund Ongoing Development and ...

LAGUNA HILLS, Calif., April 17, 2025--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment ...

Thus, the interlacing of viable and nonviable myocardium is capable of satisfying the three conditions required for initiation and maintenance of a reentrant rhythm: (1) at least two functionally (or ...